Last reviewed · How we verify
human insulin [NPH]
human insulin [NPH] is a Small molecule drug developed by Sanofi. It is currently FDA-approved.
At a glance
| Generic name | human insulin [NPH] |
|---|---|
| Sponsor | Sanofi |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- human insulin [NPH] CI brief — competitive landscape report
- human insulin [NPH] updates RSS · CI watch RSS
- Sanofi portfolio CI
Frequently asked questions about human insulin [NPH]
What is human insulin [NPH]?
human insulin [NPH] is a Small molecule drug developed by Sanofi.
Who makes human insulin [NPH]?
human insulin [NPH] is developed and marketed by Sanofi (see full Sanofi pipeline at /company/sanofi).
What development phase is human insulin [NPH] in?
human insulin [NPH] is FDA-approved (marketed).
Related
- Manufacturer: Sanofi — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing